HealthFab, a direct-to-consumer menstrual hygiene startup, has secured fresh funding in a sign of continued investor interest in women’s health and personal care brands in India’s fast-growing consumer market. The development was first reported by The Economic Times in its article titled “D2C menstrual hygiene startup HealthFab raises Rs 20 crore from Atomic Capital.”
The Bengaluru-based company raised Rs 20 crore in a funding round led by Atomic Capital, according to the report. The investment underscores a broader trend of early-stage capital flowing into specialised consumer brands that aim to address historically underserved segments, particularly in the women’s health space.
HealthFab focuses on menstrual hygiene products such as period underwear, positioning itself as an alternative to conventional disposable options. The company’s proposition combines comfort, sustainability, and convenience, targeting urban consumers who are increasingly receptive to reusable and environmentally conscious products.
The funding is expected to support HealthFab’s expansion plans, including scaling its product portfolio, strengthening supply chain capabilities, and increasing brand awareness. Like many direct-to-consumer brands, the company relies heavily on digital channels for customer acquisition and engagement, a model that has grown rapidly in India over the past few years.
Investors have shown sustained interest in D2C startups that combine niche positioning with recurring demand, and menstrual health products fit squarely within that framework. Despite being a basic necessity, the category has historically seen limited innovation and branding, leaving room for new entrants to differentiate through design, inclusivity, and sustainability.
However, the sector is becoming increasingly competitive. A growing number of startups are entering the menstrual hygiene market with offerings ranging from organic sanitary pads to menstrual cups and reusable products. This raises questions about customer retention, pricing power, and long-term profitability for emerging brands like HealthFab.
Atomic Capital’s bet reflects confidence in the category’s growth potential, particularly as awareness around menstrual health continues to rise and stigma gradually declines. Increased discourse, aided by digital platforms and changing social attitudes, has opened up new opportunities for companies seeking to normalise and innovate within this space.
The funding round also highlights a broader shift among venture investors toward consumer health and wellness segments that blend social impact with commercial viability. While the long-term success of such startups will depend on their ability to scale efficiently and compete in a crowded market, the inflow of capital suggests that investors see significant headroom for growth.
As reported by The Economic Times, HealthFab’s latest funding marks another step in its effort to build a recognisable brand in India’s evolving menstrual hygiene landscape, where changing consumer preferences are steadily reshaping a once-overlooked category.
